Acer Therapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Acer Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome (NCT05432466) | Acer Therapeutics Inc. | 2022-11-07 |
| Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause (NCT05325775) | Acer Therapeutics Inc. | 2022-03-30 |
Track Acer Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.